Epstein-Barr virus negative smooth muscle neoplasm of the stomach in a young woman

Author(s):  
Riccardo Carbone ◽  
Alessandro Vanoli ◽  
Laura Rovedatti ◽  
Marco Lucioni ◽  
Ombretta Luinetti ◽  
...  
1996 ◽  
Vol 61 (3) ◽  
pp. 515-517 ◽  
Author(s):  
Andrew M. Davidoff ◽  
Andre Hebra ◽  
Bernard J. Clark ◽  
John E. Tomaszewski ◽  
Kathleen T. Montone ◽  
...  

1998 ◽  
Vol 66 (3) ◽  
pp. 400-401 ◽  
Author(s):  
Javier Anguita ◽  
Mar??a-Luisa Rico ◽  
Jes??s Palomo ◽  
Patricia Mu??oz ◽  
Victoria Preciado ◽  
...  

1997 ◽  
Vol 27 (3-4) ◽  
pp. 303-314 ◽  
Author(s):  
Hal B. Jenson ◽  
Charles T. Leach ◽  
Kenneth L. McClain ◽  
Vijay V. Joshi ◽  
Brad H. Pollock ◽  
...  

2009 ◽  
Vol 133 (8) ◽  
pp. 1238-1241
Author(s):  
Le Yu ◽  
Anthony J. Aldave ◽  
Ben J. Glasgow

Abstract Epstein-Barr virus infection has been linked to the development of smooth muscle tumors in immunocompromised patients with organ transplants and acquired immunodeficiency syndrome. A 52-year-old female recipient of a renal transplant presented with enlarging masses of the left iris. Incisional biopsy of the mass revealed a smooth muscle tumor of the iris. Epstein-Barr virus infection was confirmed by in situ hybridization for Epstein-Barr virus–encoded, small RNA in tumor cells. Eight months after total iridectomy the patient was free of disease. Although the prognosis and classification of Epstein-Barr virus–associated smooth muscle tumors are controversial, mortalities caused by these tumors are rare.


2016 ◽  
Vol 2016 ◽  
pp. 1-4
Author(s):  
Yan Jun Li ◽  
Amila Rohan Siriwardana ◽  
James Lawrence Penn Symons ◽  
Gordon Francis O’Neill ◽  
Min Ru Qiu ◽  
...  

Leiomyomas are smooth muscle tumours that are rarely found in the kidney. There is one report of a leiomyoma in a kidney transplant in a paediatric recipient. Here, we report an adult renal transplant recipient who developed an Epstein-Barr virus-positive leiomyoma in his allograft 15 years after transplantation. The patient was converted to everolimus for posttransplant immunosuppression management and there was no sign of progression over a year.


Sign in / Sign up

Export Citation Format

Share Document